Biotech · Private company · San Diego, CA, US

Navega Therapeutics, Inc.

Track this companyFree. Adds Navega Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.

Clinical trials0None registered

Pipeline programs0None found yet

Disclosed deals0None found yet

Cash runwayNot availablePrivate: no SEC financials

NIH awards4

Reformulating NT-Z001 and its delivery route to treat rheumatoid arthritisFiscal year 2025 · $297.3KNIH RePORTER 1R43AR086088-01A1 · fetched Nov 12, 2026
Preclinical optimization of a gene therapy for erythromelalgia and chronic painFiscal year 2024 · $74.7KNIH RePORTER 3U44NS122114-03S1 · fetched Nov 12, 2026
Preclinical optimization of a gene therapy for erythromelalgia and chronic painFiscal year 2024 · $98.7KNIH RePORTER 3U44NS122114-04S1 · fetched Nov 12, 2026
Preclinical optimization of a gene therapy for erythromelalgia and chronic painFiscal year 2024 · $1.5MNIH RePORTER 5U44NS122114-04 · fetched Nov 12, 2026